Glucagon-like Peptide-1 Receptor (glp-1r) Agonists For Treating Autoimmune Disorders

Abstract

Glucagon-like peptide-1 receptor (GLP-1R) agonists are provided for reducing leukocyte invasion of the central nervous system in autoimmune diseases such as multiple sclerosis. GLP-1R agonists include, e.g., naturally-occurring agonists, such as exendin-4, as well as GLP-1R agonist peptides linked to antibodies.


Claims

Download Citation


Sign in to the Lens

Feedback